STSS (Sharps Technology, Inc.) יחס שווי שוק לשווי בספרים

The price trend shown below on GURU.Markets for medtech manufacturer Sharps Technology, Inc. (STSS), whose metric is 0.40, demonstrates a period of management adaptation to scaling production output. Growth is supported by the implementation of innovative safety syringes and the expansion of partnerships with clinics. However, geopolitical tensions and trade disputes are driving up raw material costs, creating risks for global logistics and shipments.

For long-term risk analysis, it is essential to understand how the market values the issuer's net assets relative to its market value. The current ratio of market capitalization to book value demonstrates a premium or discount to the balance sheet, where low values limit the downside but may indicate operating losses. In the case of Sharps Technology, Inc. (STSS), this indicator reflects the balance between stringent FDA regulation and the high value of intellectual property for safety syringes.